The Latest Breaking News from diabetes

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their blood sugar levels.

Researchers have now found that certain classes of weight loss and diabetes medications could be lifesavers for stroke survivors, slashing their risk of future heart attacks, strokes, and even death.

Tandem Diabetes Care sees its Relative Strength Rating reach the 80-plus level.

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints.

Learn about the crucial role that a nutritious diet plays in preventing and managing diabetes, while Laurel Deinininger-Kimmerly, a Registered Dietitian and Certified Diabetes Educator from Florida debunks common myths that could affect effective management.

It’s estimated almost 1.9 million Australians have diabetes, and numbers are growing. Between 2013 and 2023, the total number of people known to be living with diabetes across the country rose by 32%.

Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a…

A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance.

The study revealed that limiting sugar intake during early life could cut the diabetes risk by 35% and the risk of hypertension by 20%.